Physician, advocate and trusted advisor chosen for our 2023 Community Commitment Award |
Dr. Su Wang chosen for one of the Foundation's top honors.
The Hepatitis B Foundation has chosen Su Wang, MD, a New Jersey clinician and advocate living with hepatitis B, to receive its 2023 Community Commitment Award.
The presentation will take place at our Annual Gala on March 10.
Dr. Wang (far right) with Hepatitis B Foundation
team members Dr. Chari Cohen, Rhea Racho,
Maureen Kamischke and Jean Holmes
|
|
#justB Empowered: Espi's story |
Espi found out that she has hepatitis B when she was 64. For some time, she was monitored every six months, but eventually a doctor told her she could die if she didn’t begin treatment. Instead of automatically taking his advice, she researched her options. She also kept active, ate well, and tried not to worry. Finding a support group helped her to decide on her own terms to take medication, when she had all the information she needed.
Espi's story is available in English and Tagalog.
|
|
Dr. Yasmin Ibrahim appointed to national
Patient Engagement Collaborative
|
The U.S. Food and Drug Administration and the Clinical Trials Transformation Initiative (CTTI) has announced eight newly selected representatives for the Patient Engagement Collaborative, including Yasmin Ibrahim, MD, PhD, MBA, of the Hepatitis B Foundation.
According to the CTTI, “The group of 16 patients, caregivers, and patient group representatives will meet with the FDA several times a year to discuss topics such as communication, transparency, and the best ways for patients to engage the FDA about medical product regulation.”
Read more about Dr. Ibrahim and the Collaborative here.
|
|
Team Helpatitis: Students and teachers come together to raise awareness of hep B in India |
In an effort to raise awareness for hepatitis B and contribute to the World Health Organization’s (WHO) viral hepatitis elimination plan, teachers and students at Amity International School in New Delhi, India launched Team Helpatitis to promote hepatitis B education.
|
|
I love someone with hepatitis B:
Share your story
|
This Valentine's Day we want to celebrate the love we have for people living with hepatitis B. Please send your photos and a short quote about who you love with hepatitis B to info@hepb.org. Some will be shared on our Facebook, Instagram, and Twitter. Make sure you have permission from the person who is in the photo before you send it. Thank you.
|
|
New "B Heppy" podcast: Living with hepatitis delta |
Bright and Evangeline sit down with Dan to talk about his experience with hepatitis delta. We talk about his initial feelings surrounding the diagnosis, his treatment, how he got involved with the Hepatitis B Foundation, and his hope for the future of all people living with hepatitis B and delta.
Please listen here. You can find all the podcast episodes here or anywhere you get your podcasts.
AND, if you'd like to suggest a topic for B Heppy, please send an email to info@hepb.org.
|
|
Hepatitis delta: some ways to stay up to date |
Are you living with hepatitis delta? Or are you a provider caring for hepatitis B or hepatitis delta patients? Sign up to join our email list to receive important news and updates, including information about clinical trials, drug updates, events, new research, and more! We promise not to overload you with messages - only to send occasional news and relevant information about what is happening in the world of hepatitis delta.
If you or a loved one are living with hepatitis delta, please fill out this survey to sign up for the newsletter today! If you are a health care provider who manages hepatitis delta patients (or is interested in learning more about this) and would like to receive provider-specific communications from us, please let us know here. We look forward to hearing from you!
|
|
2022 Advocacy Year in Review |
As we wrap up 2022, we hope you’ll take some time to look back and celebrate the exciting and important hepatitis B policy and advocacy achievements of the past year! Community partners and grassroots advocates around the world came together to advance our shared advocacy goals and working toward the elimination of hepatitis B.
|
|
Comprehensive hepatitis B program in Vietnam provides an excellent model for other countries |
Vietnam is among the nations with the heaviest burden of hepatitis B, with at least 8% of people infected, studies have shown.
The prevalence may be closer 10%, according to Doan Y. Dao, MD, a native of Vietnam, and assistant professor at Johns Hopkins University School of Medicine. That means with a population of approximately 100 million, nearly 10 million residents may be living with hepatitis B, which in part is why Dr. Dao went into the field of hepatology and has focused on hepatitis.
|
|
Just $199 gets you access to the International HBV Meeting |
Nearly 600 scientists, clinicians and others from 31 countries attended the 2022 International HBV Meeting last month. You can access all of the groundbreaking content for $199. Learn more here.
We also have videos from the event that you can watch for free:
|
|
Thank you for making 2022 special! |
Thank you to everyone who spoke up, supported family or friends living with hepatitis B, ran in a marathon to raise awareness and funds, served on a committee, hosted a fundraiser, donated directly, signed a petition, and embraced “B the Change!” You made 2022 a special year!
Look for an Impact Report in the next month that highlights all of the important work you made possible.
Cheers to an even better 2023!
|
|
Emerging Scholars Scientific and Medical Advisory Board
journal article pick of the month
|
|
Establishing baseline framework for hepatitis B virus micro-elimination in Ho Chi Minh City, Vietnam–A community-based seroprevalence study.
Pham TN, Le DH, Dao DV, Phan LT, Pham TT, Nguyen TB,
Mize GW, Gish RG, Lee WM, Trang A, Le AN.
023 Jan 1;30:100620.
|
|
For December our presenting emerging scholar is
Julie Dang PhD, MPH, at left.
Impact: This is the first population-based community HBV study to estimate the prevalence of HBV statuses in Vietnam. Use of three sero-marker screening for HBV enabled researchers to distinguish among those who were: HBV susceptible population (negative all three seromarkers), chronic carriers (HBsAg(+)), HBV exposure with immune control (anti-HBc total (+), with or without anti-HBs), and HBV vaccination (anti-HBs(+) without HBsAg). Researchers also found wide variations in HBsAg (+) and HBV vaccination rates between districts, risk factors, and socio-economic statuses. This study demonstrated the feasibility of conducting a large-scale comprehensive HBV screening and access to care program in an HBV endemic country that involved collaboration among diverse stakeholders including government, health care institutions, community organizations, and private sector.
|
|
March 10 - William S. Mason Symposium
Details TBA
March 10 - Hepatitis B Foundation Gala
|
|
Learn more about our research and education programs at www.hepb.org
|
|
The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. Our commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community, and the general public. |
|
|
|
Hepatitis B Foundation I 3805 Old Easton Road Doylestown, PA 18902 I
215-489-4900 I info@hepb.org
|
|
|
|
|
|
|
